278 related articles for article (PubMed ID: 32024849)
1. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Jiao W; Atwal G; Polak P; Karlic R; Cuppen E; ; Danyi A; de Ridder J; van Herpen C; Lolkema MP; Steeghs N; Getz G; Morris QD; Stein LD;
Nat Commun; 2020 Feb; 11(1):728. PubMed ID: 32024849
[TBL] [Abstract][Full Text] [Related]
2. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
3. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
5. Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020.
Giunta S
Cancer Metastasis Rev; 2021 Sep; 40(3):909-924. PubMed ID: 34097189
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
[TBL] [Abstract][Full Text] [Related]
7. A user guide for the online exploration and visualization of PCAWG data.
Goldman MJ; Zhang J; Fonseca NA; Cortés-Ciriano I; Xiang Q; Craft B; Piñeiro-Yáñez E; O'Connor BD; Bazant W; Barrera E; Muñoz-Pomer A; Petryszak R; Füllgrabe A; Al-Shahrour F; Keays M; Haussler D; Weinstein JN; Huber W; Valencia A; Park PJ; Papatheodorou I; Zhu J; Ferretti V; Vazquez M
Nat Commun; 2020 Jul; 11(1):3400. PubMed ID: 32636365
[TBL] [Abstract][Full Text] [Related]
8. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Rubanova Y; Shi R; Harrigan CF; Li R; Wintersinger J; Sahin N; Deshwar AG; ; Morris QD;
Nat Commun; 2020 Feb; 11(1):731. PubMed ID: 32024834
[TBL] [Abstract][Full Text] [Related]
9. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.
Kumar S; Warrell J; Li S; McGillivray PD; Meyerson W; Salichos L; Harmanci A; Martinez-Fundichely A; Chan CWY; Nielsen MM; Lochovsky L; Zhang Y; Li X; Lou S; Pedersen JS; Herrmann C; Getz G; Khurana E; Gerstein MB
Cell; 2020 Mar; 180(5):915-927.e16. PubMed ID: 32084333
[TBL] [Abstract][Full Text] [Related]
10. Passenger mutations accurately classify human tumors.
Salvadores M; Mas-Ponte D; Supek F
PLoS Comput Biol; 2019 Apr; 15(4):e1006953. PubMed ID: 30986244
[TBL] [Abstract][Full Text] [Related]
11. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
Shuai S; ; Gallinger S; Stein LD;
Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
[TBL] [Abstract][Full Text] [Related]
13. Divergent mutational processes distinguish hypoxic and normoxic tumours.
Bhandari V; Li CH; Bristow RG; Boutros PC;
Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
[TBL] [Abstract][Full Text] [Related]
14. Mutational concordance analysis provides supportive information for double cancer diagnosis.
Hatakeyama K; Nagashima T; Notsu A; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Naruoka A; Maruyama K; Iizuka A; Ashizawa T; Kenmotsu H; Mochizuki T; Urakami K; Akiyama Y; Yamaguchi K
BMC Cancer; 2021 Feb; 21(1):181. PubMed ID: 33607950
[TBL] [Abstract][Full Text] [Related]
15. Inferring structural variant cancer cell fraction.
Cmero M; Yuan K; Ong CS; Schröder J; ; Corcoran NM; Papenfuss T; Hovens CM; Markowetz F; Macintyre G;
Nat Commun; 2020 Feb; 11(1):730. PubMed ID: 32024845
[TBL] [Abstract][Full Text] [Related]
16. Pathway and network analysis of more than 2500 whole cancer genomes.
Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
[TBL] [Abstract][Full Text] [Related]
18. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
19. The evolutionary history of 2,658 cancers.
Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P;
Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013
[TBL] [Abstract][Full Text] [Related]
20. Deep learning model accurately classifies metastatic tumors from primary tumors based on mutational signatures.
Zheng W; Pu M; Li X; Du Z; Jin S; Li X; Zhou J; Zhang Y
Sci Rep; 2023 May; 13(1):8752. PubMed ID: 37253775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
